Phase 1 Chronic HBV Infection Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Study of LW231 in Participants With Chronic Hepatitis B
Chronic HBV Infection
Shanghai Longwood Biopharmaceuticals Co., Ltd.270 enrolled2 locationsNCT07179575
Withdrawn
Phase 1
A Study to investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AB-452 in Healthy Subjects and Subjects with Chronic HBV Infection
Chronic HBV Infection
Arbutus Biopharma Corporation76 enrolled6 locationsACTRN12618001438246
Terminated
Phase 1
A study to investigate the Safety, Tolerability, and Pharmacokinetics of AB-506 in Healthy Subjects and Subjects with Chronic HBV Infection
Chronic HBV Infection
Arbutus Biopharma Corporation76 enrolled5 locationsACTRN12618000987268